Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Anastasia A Kovpak"'
Autor:
Alexander G. Litov, Alexey M. Shchetinin, Ivan S. Kholodilov, Oxana A. Belova, Magomed N. Gadzhikurbanov, Anna Y. Ivannikova, Anastasia A. Kovpak, Vladimir A. Gushchin, Galina G. Karganova
Publikováno v:
Viruses, Vol 16, Iss 4, p 576 (2024)
Cell cultures derived from ticks have become a commonly used tool for the isolation and study of tick-borne pathogens and tick biology. The IRE/CTVM19 cell line, originating from embryos of Ixodes ricinus, is one such line. Previously, reovirus-like
Externí odkaz:
https://doaj.org/article/01cf9f89a288457696250bcc4f34dd6c
Autor:
Ilya V. Gordeychuk, Liubov I. Kozlovskaya, Aleksandra A. Siniugina, Nadezhda V. Yagovkina, Vladimir I. Kuzubov, Konstantin A. Zakharov, Viktor P. Volok, Maria S. Dodina, Larissa V. Gmyl, Natalya A. Korotina, Rostislav D. Theodorovich, Yulia I. Ulitina, Dmitry I. Vovk, Marina V. Alikova, Anna A. Kataeva, Anna V. Kalenskaya, Irina V. Solovjeva, Elena V. Tivanova, Larissa Y. Kondrasheva, Antonina A. Ploskireva, Vasiliy G. Akimkin, Ksenia A. Subbotina, Georgy M. Ignatyev, Anastasia K. Korduban, Elena Y. Shustova, Ekaterina O. Bayurova, Alla S. Zhitkevich, Daria V. Avdoshina, Anastasia N. Piniaeva, Anastasia A. Kovpak, Liliya P. Antonova, Yulia V. Rogova, Anna A. Shishova, Yury Y. Ivin, Svetlana E. Sotskova, Konstantin A. Chernov, Elena G. Ipatova, Ekaterina A. Korduban, Aydar A. Ishmukhametov
Publikováno v:
Viruses, Vol 15, Iss 9, p 1828 (2023)
We present the results of a randomized, double-blind, placebo-controlled, multi-center clinical trial phase I/II of the tolerability, safety, and immunogenicity of the inactivated whole virion concentrated purified coronavirus vaccine CoviVac in volu
Externí odkaz:
https://doaj.org/article/888b158eaf434d709bf07e578aead9e6
Autor:
Nadezhda V. Yagovkina, Lev M. Zheleznov, Ksenia A. Subbotina, Andrey A. Tsaan, Liubov I. Kozlovskaya, Ilya V. Gordeychuk, Anastasia K. Korduban, Yury Y. Ivin, Anastasia A. Kovpak, Anastasia N. Piniaeva, Anna A. Shishova, Elena Y. Shustova, Yusuf K. Khapchaev, Galina G. Karganova, Alexandra A. Siniugina, Tatiana V. Pomaskina, Aleksandr A. Erovichenkov, Konstantin Chumakov, Aydar A. Ishmukhametov
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundEffective response to emerging pandemic threats is complicated by the need to develop specific vaccines and other medical products. The availability of broadly specific countermeasures that could be deployed early in the pandemic could sign
Externí odkaz:
https://doaj.org/article/bbeca342ee3848b59babc5aa3a6847f5
Autor:
Liubov I. Kozlovskaya, Anastasia N. Piniaeva, Georgy M. Ignatyev, Ilya V. Gordeychuk, Viktor P. Volok, Yulia V. Rogova, Anna A. Shishova, Anastasia A. Kovpak, Yury Yu. Ivin, Liliya P. Antonova, Kirill M. Mefyod, Lyubov S. Prokosheva, Anna S. Sibirkina, Yuliya Yu. Tarasova, Ekaterina O. Bayurova, Olga S. Gancharova, Victoria V. Illarionova, Grigory S. Glukhov, Olga S. Sokolova, Konstantin V. Shaitan, Anastasia M. Moysenovich, Stanislav A. Gulyaev, Tatiana V. Gulyaeva, Andrey V. Moroz, Larissa V. Gmyl, Elena G. Ipatova, Mikhail P. Kirpichnikov, Alexey M. Egorov, Aleksandra A. Siniugina, Aydar A. Ishmukhametov
Publikováno v:
Emerging Microbes and Infections, Vol 10, Iss 1, Pp 1790-1806 (2021)
The unprecedented in recent history global COVID-19 pandemic urged the implementation of all existing vaccine platforms to ensure the availability of the vaccines against COVID-19 to every country in the world. Despite the multitude of high-quality p
Externí odkaz:
https://doaj.org/article/25dd68ffe74e41b1a33bb195f5965272
Autor:
Anastasia A. Kovpak, Anastasia N. Piniaeva, Oleg A. Gerasimov, Irina O. Tcelykh, Mayya Y. Ermakova, Anna N. Zyrina, Dmitry V. Danilov, Yury Y. Ivin, Liubov I. Kozlovskaya, Aydar A. Ishmukhametov
Publikováno v:
Vaccines, Vol 10, Iss 6, p 949 (2022)
Various types of COVID-19 vaccines, including adenovirus, mRNA, and inactivated ones, have been developed and approved for clinical use worldwide. Inactivated vaccines are produced using a proven technology that is widely used for the production of v
Externí odkaz:
https://doaj.org/article/f8c8d0bebff3422ab3318ea190b369ee
Autor:
Aydar A Ishmukhametov, Aleksandra A Siniugina, Nadezhda V Yagovkina, Vladimir I Kuzubov, Konstantin A Zakharov, Viktor P Volok, Maria S Dodina, Larissa V Gmyl, Natalya A Korotina, Rostislav D Theodorovich, Yulia I Ulitina, Andrey A Tsaan, Tatiana V Pomaskina, Anna V Kalenskaya, Irina V Solovjeva, Elena V Tivanova, Larissa Y Kondrasheva, Antonina A Ploskireva, Vasiliy G Akimkin, Ksenia A Subbotina, Georgy M Ignatyev, Anastasia K Korduban, Elena Y Shustova, Ekaterina O Bayurova, Alla S Kondrashova, Darya V Avdoshina, Anastasia N Piniaeva, Anastasia A Kovpak, Liliya P Antonova, Yulia V Rogova, Anna A Shishova, Yury Y Ivin, Svetlana E Sotskova, Konstantin A Chernov, Elena G Ipatova, Ekaterina A Korduban, Liubov I Kozlovskaya, Ilya V Gordeychuk
We present the results of a randomized, double-blind, placebo-controlled, multi-center clinical trial of the tolerability, safety, and immunogenicity of the inactivated whole virion concentrated purified coronavirus vaccine CoviVac in adult volunteer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fa7f5e2e5807fe5981592d7795102a1
https://doi.org/10.1101/2022.02.08.22270658
https://doi.org/10.1101/2022.02.08.22270658
Autor:
Piniaeva A; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI 'Chumakov FSC R&D IBP RAS'), 108819 Moscow, Russia., Ignatyev G; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI 'Chumakov FSC R&D IBP RAS'), 108819 Moscow, Russia., Kozlovskaya L; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI 'Chumakov FSC R&D IBP RAS'), 108819 Moscow, Russia.; Institute for Translational Medicine and Biotechnology, First Moscow State Medical University (Sechenov University), 117418 Moscow, Russia., Ivin Y; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI 'Chumakov FSC R&D IBP RAS'), 108819 Moscow, Russia., Kovpak A; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI 'Chumakov FSC R&D IBP RAS'), 108819 Moscow, Russia., Ivanov A; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI 'Chumakov FSC R&D IBP RAS'), 108819 Moscow, Russia., Shishova A; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI 'Chumakov FSC R&D IBP RAS'), 108819 Moscow, Russia.; Institute for Translational Medicine and Biotechnology, First Moscow State Medical University (Sechenov University), 117418 Moscow, Russia., Antonova L; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI 'Chumakov FSC R&D IBP RAS'), 108819 Moscow, Russia., Khapchaev Y; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI 'Chumakov FSC R&D IBP RAS'), 108819 Moscow, Russia., Feldblium I; Perm State Medical University Named after Academician E.A. Wagner, 614990 Perm, Russia., Ivanova O; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI 'Chumakov FSC R&D IBP RAS'), 108819 Moscow, Russia.; Institute for Translational Medicine and Biotechnology, First Moscow State Medical University (Sechenov University), 117418 Moscow, Russia., Siniugina A; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI 'Chumakov FSC R&D IBP RAS'), 108819 Moscow, Russia., Ishmukhametov A; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products RAS (FSBSI 'Chumakov FSC R&D IBP RAS'), 108819 Moscow, Russia.; Institute for Translational Medicine and Biotechnology, First Moscow State Medical University (Sechenov University), 117418 Moscow, Russia.
Publikováno v:
Vaccines [Vaccines (Basel)] 2021 May 29; Vol. 9 (6). Date of Electronic Publication: 2021 May 29.
Autor:
Kozlovskaya L; FSBSI 'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), Moscow 108819, Russia; Sechenov Moscow State Medical University, Moscow 119991, Russia., Piniaeva A; FSBSI 'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), Moscow 108819, Russia., Ignatyev G; FSBSI 'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), Moscow 108819, Russia., Selivanov A; FSBSI 'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), Moscow 108819, Russia., Shishova A; FSBSI 'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), Moscow 108819, Russia; Sechenov Moscow State Medical University, Moscow 119991, Russia., Kovpak A; FSBSI 'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), Moscow 108819, Russia., Gordeychuk I; FSBSI 'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), Moscow 108819, Russia; Sechenov Moscow State Medical University, Moscow 119991, Russia., Ivin Y; FSBSI 'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), Moscow 108819, Russia., Berestovskaya A; GKB No. 40 DZM, Moscow 129301, Russia., Prokhortchouk E; Institute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow 119071, Russia., Protsenko D; GKB No. 40 DZM, Moscow 129301, Russia., Rychev M; NRC 'Kurchatov Institute', Moscow 123182, Russia., Ishmukhametov A; FSBSI 'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), Moscow 108819, Russia; Sechenov Moscow State Medical University, Moscow 119991, Russia.
Publikováno v:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2021 Feb; Vol. 103, pp. 644. Date of Electronic Publication: 2021 Jan 02.
Autor:
Kozlovskaya L; FSBSI 'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), Moscow 108819, Russia; Sechenov Moscow State Medical University, Moscow 119991, Russia. Electronic address: lubov_i_k@mail.ru., Piniaeva A; FSBSI 'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), Moscow 108819, Russia., Ignatyev G; FSBSI 'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), Moscow 108819, Russia., Selivanov A; FSBSI 'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), Moscow 108819, Russia., Shishova A; FSBSI 'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), Moscow 108819, Russia; Sechenov Moscow State Medical University, Moscow 119991, Russia., Kovpak A; FSBSI 'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), Moscow 108819, Russia., Gordeychuk I; FSBSI 'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), Moscow 108819, Russia; Sechenov Moscow State Medical University, Moscow 119991, Russia., Ivin Y; FSBSI 'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), Moscow 108819, Russia., Berestovskaya A; GKB No. 40 DZM, Moscow 129301, Russia., Prokhortchouk E; NRC 'Kurchatov Institute', Moscow 123182, Russia., Protsenko D; GKB No. 40 DZM, Moscow 129301, Russia., Rychev M; NRC 'Kurchatov Institute', Moscow 123182, Russia., Ishmukhametov A; FSBSI 'Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), Moscow 108819, Russia; Sechenov Moscow State Medical University, Moscow 119991, Russia.
Publikováno v:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2020 Oct; Vol. 99, pp. 40-46. Date of Electronic Publication: 2020 Jul 25.